Quarry LP’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Quarry LP’s Portfolio DMAA Stock Details DMAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$698K	Sell	65,551 -201,000	-75%	-$2.13M	0.06%	117
2026 Q1	$2.8M	Hold	266,551	–	–	0.5%	38
2025 Q4	$2.77M	Buy	266,551 +250,830	+1,596%	+$2.59M	0.43%	34
2025 Q3	$161K	Buy	+15,721	New	+$161K	0.04%	413
2025 Q2	–	Sell	-650,000	Closed	-$6.51M	–	2149
2025 Q1	$6.51M	Buy	+650,000	New	+$6.5M	1.41%	10

Other funds holding DMAA

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Quarry LP's DMAA Position: Q2 2026 in Review

Quarry LP reduced its Drugs Made In America Acquisition Corp (DMAA) stake by 75% in Q2 2026, selling an estimated $2.13M and leaving 65,551 shares worth $698K. The position accounts for 0.06% of the portfolio, ranked #117.

Quarry LP first reported a position in DMAA in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.51M in Q1 2025. 23 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

Quarry LP held 65,551 shares of Drugs Made In America Acquisition Corp worth $698K as of Q2 2026.
Quarry LP sold 201,000 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $2.13M.
Drugs Made In America Acquisition Corp made up 0.06% of Quarry LP's portfolio in Q2 2026, its #117 holding.
Quarry LP first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
Quarry LP's Drugs Made In America Acquisition Corp position peaked at $6.51M in Q1 2025.
23 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.